ARCHIVES

Communication Is Key To Clinical Trial Enrollment

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

Prostate Cancer Council Calls For Long-Term Screening Research

September 10, 1993

Gottlieb questions ODAC’s independence.

August 5, 2005

Year 2000 Objectives In Health On Track

June 25, 1999

Upon, Panel Lean To Anecdotal Laetrile Study

August 12, 1977